Free to Read
Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting: Clinical Outcomes in Multivessel Coronary Artery Disease
C. SAMUEL LEDFORD M.D.,
CINDY L. GRINES M.D.,
C. SAMUEL LEDFORD M.D.
Department of Medicine, Division of Cardiology, William Beaumont Hospital, Royal Oak, Michigan
Search for more papers by this authorCorresponding Author
CINDY L. GRINES M.D.
Department of Medicine, Division of Cardiology, William Beaumont Hospital, Royal Oak, Michigan
Cindy L. Grines, M.D., William Beaumont Hospital, Division of Cardiology, 3601 W. Thirteen Mile Rd., Royal Oak, MI 48073. Fax: (248) 551–8806; [email protected]Search for more papers by this authorC. SAMUEL LEDFORD M.D.,
CINDY L. GRINES M.D.,
C. SAMUEL LEDFORD M.D.
Department of Medicine, Division of Cardiology, William Beaumont Hospital, Royal Oak, Michigan
Search for more papers by this authorCorresponding Author
CINDY L. GRINES M.D.
Department of Medicine, Division of Cardiology, William Beaumont Hospital, Royal Oak, Michigan
Cindy L. Grines, M.D., William Beaumont Hospital, Division of Cardiology, 3601 W. Thirteen Mile Rd., Royal Oak, MI 48073. Fax: (248) 551–8806; [email protected]Search for more papers by this authorFirst published: 13 August 2007
Abstract
Revascularization with percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) is superior to medical management in reducing symptoms and prolonging exercise duration in patients with coronary artery disease (CAD). Ten randomized trials have compared the outcomes in percutaneous and surgically treated patients with multivessel CAD. The purpose of this article was to summarize the results of those trials to make recommendations regarding appropriate revascularization strategy.
References
- 1 Heart and Stroke Statistical Update, AHA, 2001.
- 2 Yusuf S, Zucker D, Peduzzi P, et al. Effect of coronary artery bypass graft surgery on survival: Overview of 10-year results from randomized trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet 1994; 344: 563–570.
- 3 Bucher HC, Hengstler P, Schindler C, et al. Percutaneous transluminal coronary angioplasty versus medical treatment for non-acute coronary heart disease: Meta-analysis of randomized controlled trials. BMJ 2000; 321: 73–79.
- 4 RITA Trial Participants. Coronary angioplasty versus coronary artery bypass surgery: The Randomized Intervention Treatment of Angina (RITA) trial. Lancet 1993; 341: 573–580.
- 5 Henderson RA, Popcock SJ, Sharp SJ, et al., For the Randomized Intervention Treatment of Angina (RITA-I) trial participants. Long-term results of RITA-I trial: Clinical and cost comparisons of coronary angioplasty and coronary-artery bypass grafting. Lancet 1998; 352: 1419–1425.
- 6 The Bypass Angioplasty Revascularization Investigation (BART) Investigators. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. N Engl J Med 1996; 335: 217–225.
- 7 Hamm CW, Reimer J, Ischinger T, et al. A randomized study of coronary angioplasty compared with bypass surgery in patients with symptomatic multivessel coronary disease. N Engl J Med 1994; 331: 1037–1043.
- 8 King, SB III, Lembo NJ, Weintraub WS, et al. A randomized trial comparing coronary angioplasty with coronary bypass surgery. N Engl J Med 1994; 331: 1044–1050.
- 9 CABRI Trial Participants. Coronary Angioplasty vs Bypass Revascularization Investigation (CABRI) results during the first year. Lancet 1995; 346: 1179–1183.
- 10 Rodriguez A, Boullon F, Perez Balino N, et al. Argentine randomized trial of percutaneous transluminal coronary angioplasty versus coronary artery bypass surgery in multivessel disease (ERACI): In hospital and 1-year follow-up. J Am Coll Cardiol 1992; 33: 1060–1067.
- 11 Rodriguez A, Bernardi V, Navia J, et al. Argentine Randomized Study: Coronary Angioplasty with stenting versus Coronary Artery Bypass Surgery in patient with Multiple-Vessel Disease (ERACI II): 30-day and one-year follow-up results. ERACIII Investigators. J Am Coll Cardiol 2001; 37: 51–58.
- 12 Arterial Revascularization Therapies Study Group. Comparison of Coronary artery bypass surgery and stenting for treatment of multivessel disease. N Engl J Med 344;15: 1117–1124.
- 13 Hueb W. The Medicine, Angioplasty or Surgery Study (MASS II) Trial: A randomized, controlled clinical trial of medical therapy, coronary angioplasty, or bypass surgery for multivessel coronary artery disease. J Am Coll Cardiol 2001; 38: 597.
- 14 Morrison DA, Sethi G, Sacks J, et al. Percutaneous coronary intervention versus coronary artery bypass graft surgery for patients with medically refractory myocardial ischemia and risk factors for adverse outcomes with bypass: A multicenter, randomized trial. J Am Coll Cardiol 2001; 38: 143–149.
- 15 Chaitman BR, Rosen AD, Williams DO, et al., On behalf of the BARI Investigators. Myocardial infarction and cardiac mortality in the Bypass Angioplasty Revascularization Investigation (BARI) randomized trial. Circulation 1997; 96: 2162–2170.
- 16 The BARI Investigators. Seven-year outcome in the bypass angioplasty revascularization investigation (BARI) by treatment and diabetic status. J Am Coll Cardiol 2000; 35: 1122–1129.
- 17 King SB III, Kosinski AS, Guyton RA, et al. Eight year mortality in the Emory Angioplasty versus Surgery Trial (EAST) J Am Coll Cardiol 2000; 35: 1116–1121.
- 18 Kurbaan AS, Bowker TJ, Ilsley CD, et al. Difference in the mortality of the CABRI diabetic and nondiabetic populations and its relation to coronary artery disease and revascularization mode. Am J Cardiol 2001; 87: 947–590.
- 19 Berger PB, Velianou JL, Aslanidou VH, et al. Survival following angioplasty versus coronary artery bypass surgery in anatomic subsets in which coronary artery bypass surgery improves survival compared with medical therapy. Results of the Bypass Angioplasty Revascularization Investigation (BARI). J Am Coll Cardiol 2001; 38: 1440–1449.
- 20 Weintraub WS, Becker ER, Mauldin PD, et al. Cost of revascularization over eight years in the randomized and eligible patients in the Emory angioplasty versus surgery trial (EAST). Am J Cardiol 2000; 86: 747–752.
